Sébastien Perreault

4.1k total citations
70 papers, 1.5k citations indexed

About

Sébastien Perreault is a scholar working on Neurology, Genetics and Molecular Biology. According to data from OpenAlex, Sébastien Perreault has authored 70 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Neurology, 37 papers in Genetics and 17 papers in Molecular Biology. Recurrent topics in Sébastien Perreault's work include Glioma Diagnosis and Treatment (37 papers), Neuroblastoma Research and Treatments (24 papers) and Neurofibromatosis and Schwannoma Cases (18 papers). Sébastien Perreault is often cited by papers focused on Glioma Diagnosis and Treatment (37 papers), Neuroblastoma Research and Treatments (24 papers) and Neurofibromatosis and Schwannoma Cases (18 papers). Sébastien Perreault collaborates with scholars based in Canada, United States and Germany. Sébastien Perreault's co-authors include Nicole Leclerc, Dalinda Liazoghli, Jacques Paiement, Michel Lauzon, Paul G. Fisher, Nada Jabado, Kristen W. Yeom, Éric Bouffet, Vijay Ramaswamy and L. E. Bergeron and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Neurology.

In The Last Decade

Sébastien Perreault

63 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sébastien Perreault Canada 20 659 509 388 174 162 70 1.5k
Jordan Xu United States 8 597 0.9× 319 0.6× 257 0.7× 281 1.6× 261 1.6× 22 1.3k
Daniel Crooks United Kingdom 17 393 0.6× 425 0.8× 224 0.6× 176 1.0× 168 1.0× 42 1.3k
Niklas Schäfer Germany 21 560 0.8× 213 0.4× 287 0.7× 300 1.7× 159 1.0× 78 1.2k
Zoltán Patay United States 25 740 1.1× 462 0.9× 456 1.2× 200 1.1× 306 1.9× 105 2.0k
Robert J. Bollo United States 20 375 0.6× 688 1.4× 376 1.0× 133 0.8× 112 0.7× 74 2.0k
Timothée Lenglet France 22 500 0.8× 349 0.7× 870 2.2× 159 0.9× 115 0.7× 58 1.6k
Joseph Megyesi Canada 22 524 0.8× 283 0.6× 544 1.4× 337 1.9× 232 1.4× 57 1.5k
Arne Fischmann Switzerland 21 341 0.5× 812 1.6× 174 0.4× 136 0.8× 146 0.9× 49 1.8k
Atik Baborie United Kingdom 16 466 0.7× 417 0.8× 540 1.4× 129 0.7× 95 0.6× 33 1.1k

Countries citing papers authored by Sébastien Perreault

Since Specialization
Citations

This map shows the geographic impact of Sébastien Perreault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Perreault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Perreault more than expected).

Fields of papers citing papers by Sébastien Perreault

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Perreault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Perreault. The network helps show where Sébastien Perreault may publish in the future.

Co-authorship network of co-authors of Sébastien Perreault

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Perreault. A scholar is included among the top collaborators of Sébastien Perreault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Perreault. Sébastien Perreault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Perreault, Sébastien, Marjolein Geurts, Jasia Mahdi, et al.. (2025). Point/counterpoint: Upfront BRAF inhibition for adult BRAF-mutant high-grade gliomas. Neuro-Oncology. 27(11). 2804–2811.
2.
Silverman, Jacob, Hallie Coltin, Geneviève Legault, et al.. (2025). Sustained response to trametinib in an adult patient with neurofibromatosis type 1 and high-grade glioma. Child s Nervous System. 41(1). 202–202.
3.
Lafay‐Cousin, Lucie, et al.. (2025). A National Modified Delphi Consensus on the Referral and Management of NF1 Plexiform Neurofibroma. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 1–9.
4.
Duval, Michel, et al.. (2024). Quality-of-Life Assessment in Pediatric Advanced Cancer: Development of the Patient-Reported Outcome Measure Advance QoL. Current Oncology. 31(4). 2289–2304. 1 indexed citations
5.
Martinez, Matthew W., Sébastien Perreault, Geneviève Legault, et al.. (2024). Advances in pediatric gliomas: from molecular characterization to personalized treatments. European Journal of Pediatrics. 183(6). 2549–2562. 2 indexed citations
6.
Knoth, Inga Sophia, et al.. (2023). Time-frequency analyses of repetition suppression and change detection in children with neurofibromatosis type 1. Brain Research. 1818. 148512–148512. 2 indexed citations
7.
Das, Sunit, Sébastien Perreault, Stephen Yip, et al.. (2023). INNV-35. IMPLEMENTATION OF A NATIONAL ADOLESCENT AND YOUNG ADULT MOLECULAR TUMOR BOARD: REPORT FROM THE CANADIAN AYA NEURO-ONCOLOGY NETWORK. Neuro-Oncology. 25(Supplement_5). v164–v164.
8.
D’Onofrio, Gianluca, Marie‐Ange Delrue, Anne Lortie, et al.. (2023). Treatment of Refractory Epilepsy With MEK Inhibitor in Patients With RASopathy. Pediatric Neurology. 148. 148–151. 9 indexed citations
9.
Tilburg, Cornelis M. van, Lindsay Kilburn, Erin Crotty, et al.. (2023). LOGGIC/FIREFLY-2: A phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration.. Journal of Clinical Oncology. 41(16_suppl). TPS10067–TPS10067. 4 indexed citations
10.
Lim-Fat, Mary Jane, Sarah Lapointe, Chantel Cacciotti, et al.. (2022). Molecular testing for adolescent and young adult central nervous system tumors: A Canadian guideline. Frontiers in Oncology. 12. 960509–960509. 10 indexed citations
11.
Perreault, Sébastien, Valérie Larouche, Uri Tabori, et al.. (2019). A phase 2 study of trametinib for patients with pediatric glioma or plexiform neurofibroma with refractory tumor and activation of the MAPK/ERK pathway: TRAM-01. BMC Cancer. 19(1). 1250–1250. 109 indexed citations
12.
Dudley, Roy, et al.. (2019). Efficacy of Dabrafenib for three children with brainstem BRAFV600E positive ganglioglioma. Journal of Neuro-Oncology. 145(1). 135–141. 9 indexed citations
13.
Iv, Michael, Mu Zhou, Katie Shpanskaya, et al.. (2018). MR Imaging–Based Radiomic Signatures of Distinct Molecular Subgroups of Medulloblastoma. American Journal of Neuroradiology. 40(1). 154–161. 81 indexed citations
14.
Weil, Alexander G., Katherine Muir, Juliette Hukin, et al.. (2018). Narcolepsy and Hypothalamic Region Tumors: Presentation and Evolution. Pediatric Neurology. 84. 27–31. 18 indexed citations
15.
Perreault, Sébastien, Vijay Ramaswamy, Achal S. Achrol, et al.. (2014). MRI Surrogates for Molecular Subgroups of Medulloblastoma. American Journal of Neuroradiology. 35(7). 1263–1269. 190 indexed citations
16.
Perreault, Sébastien, et al.. (2014). Sports and childhood brain tumors: Can I play?. Neuro-Oncology Practice. 1(4). 158–165. 3 indexed citations
17.
Perreault, Sébastien, Robert M. Lober, Anne‐Sophie Carret, et al.. (2013). Relapse patterns in pediatric embryonal central nervous system tumors. Journal of Neuro-Oncology. 115(2). 209–215. 21 indexed citations
18.
Perreault, Sébastien, Geneviève Bernard, Anne Lortie, Françoise Le Deist, & Hélène Decaluwe. (2012). Ataxia-Telangiectasia Presenting With a Novel Immunodeficiency. Pediatric Neurology. 46(5). 322–324. 9 indexed citations
19.
Perreault, Sébastien, Olivier Bousquet, Michel Lauzon, Jacques Paiement, & Nicole Leclerc. (2009). Increased Association Between Rough Endoplasmic Reticulum Membranes and Mitochondria in Transgenic Mice That Express P301L Tau. Journal of Neuropathology & Experimental Neurology. 68(5). 503–514. 61 indexed citations
20.
Liazoghli, Dalinda, et al.. (2005). Fragmentation of the Golgi Apparatus Induced by the Overexpression of Wild-Type and Mutant Human Tau Forms in Neurons. American Journal Of Pathology. 166(5). 1499–1514. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jordan Xu Breakdown of academic impact, for papers by Daniel Crooks Breakdown of academic impact, for papers by Niklas Schäfer Breakdown of academic impact, for papers by Zoltán Patay Breakdown of academic impact, for papers by Robert J. Bollo Breakdown of academic impact, for papers by Timothée Lenglet Breakdown of academic impact, for papers by Joseph Megyesi Breakdown of academic impact, for papers by Arne Fischmann Breakdown of academic impact, for papers by Atik Baborie
Rankless by CCL
2026